Is the coprescription of β blockers and β2 agonists justified in COPD? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Letters

PostScript

Is the coprescription of β blockers and β₂agonists justified in COPD?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Singh A

Is the coprescription of β blockers and β₂agonists justified in COPD?

Thorax 2008;63:1026.